R. Ferrara

Short term treatment with Escheria coli recombinant human granulocyte‐macrophage–colony stimulating factor prior to chemotherapy for Hodgkin disease

G. Castoldi, F. Montemurro, M. Aglietta, 2000, Cancer.

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

N. Rigby, R. Van Ree, M. Kowalski, 2015, International Archives of Allergy and Immunology.

FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

N. Rigby, R. Van Ree, C. Mills, 2012, Clinical and Translational Allergy.

Lipid transfer proteins: the most frequent sensitizer in Italian subjects with food‐dependent exercise‐induced anaphylaxis

A. Romano, A. Mari, V. Palmieri, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

N. Rigby, N. Papadopoulos, M. Fernández-Rivas, 2015, International archives of allergy and immunology.